
A community oncology pharmacist explains how seeing patients across the course of their diagnosis builds trust and why accessibility remains the field’s biggest challenge despite advances in AI.
Grant Knowles, PharmD, vice president, Business Development, Ardon Health, discusses the potential impact biosimilars will have in health care.
Knowles: I think any time you introduce competition into an environment, there's a lot of opportunities for economic gains--they can be positive, they can be negative. I think it will be interested to watch to see as biosimilars are launched and see the traction with health plans and pharmacies.